Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | -9.98% |
|
-.--% | +29.82% |
27/06 | Hansa Biopharma AB Announces Board Appointments | CI |
31/05 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HANSA BIOPHARMA AB | Other Biotechnology & Medical Research | -9.98% | -.--% | +29.82% | -44.66% | -85.31% | 311M | - | - | - |
- Stock Market
- Equities
- HNSA Stock
- HNSBF Stock
- Charts Hansa Biopharma AB
- Relative Strength Chart